Description
Have you ever thought about how studying philosophy could make you a better coder? Goldman Sachs' CIO Marco Argenti recently suggested that AI engineers dive into philosophy alongside their technical studies to enhance the quality of their code. While this idea may seem unconventional, it underscores a vital truth in the age of AI: soft skills and a human touch are just as essential as technical expertise.
In this episode of Tech Talks Daily, I'm joined by Rob Whiteley, CEO of Coder, to discuss what qualities organizations should seek in a coder beyond deep technical knowledge. We'll explore the importance of critical thinking, creativity, and human understanding, and delve into what coders should be studying to become well-rounded and successful. As AI increasingly becomes a go-to tool for faster coding, how can we ensure it doesn’t compromise quality and effectiveness?
Rob will share insights on the value of a broad liberal arts education, the need for continuous learning, and the crucial role of soft skills in the coding profession. We'll also tackle the ethical and intellectual property concerns surrounding AI-assisted coding, and why the human element remains indispensable for innovation and quality assurance.
Join us for a thought-provoking conversation that challenges conventional wisdom and highlights the multifaceted nature of coding in today's AI-driven world. What are your thoughts on the balance between technical skills and soft skills in coding? How do you see the role of AI shaping the future of software development? I'd love to hear your insights.
In this episode of Tech Talks Daily, I enjoy a conversation with Rebecca Wooters, the Chief Digital Officer at Signet Jewelers, the world’s largest diamond retailer.
With renowned brands like Kay, Zales, Jared, and James Allen under its umbrella, Signet is revolutionizing the jewelry industry...
Published 09/07/24
In this episode, I have an insightful conversation with Chris Hart, the CEO of Creyon Bio, to dive into how artificial intelligence is reshaping drug development.
Creyon Bio is pioneering the use of AI to engineer Oligonucleotide-Based Medicines (OBMs), prioritizing safety in their approach to...
Published 09/06/24